Mechanism of Salutary Effects of Astringinin on Rodent Hepatic Injury following Trauma-Hemorrhage: Akt-Dependent Hemeoxygenase-1 Signaling Pathways by Liu, Fu-Chao et al.
Mechanism of Salutary Effects of Astringinin on Rodent
Hepatic Injury following Trauma-Hemorrhage: Akt-
Dependent Hemeoxygenase-1 Signaling Pathways
Fu-Chao Liu
1,2, Tsong-Long Hwang
3, Ying-Tung Lau
4,5, Huang-Ping Yu
1,2*
1Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 2College of Medicine, Chang Gung University, Taoyuan, Taiwan, 3Graduate Institute
of Natural Products, Chang Gung University, Taoyuan, Taiwan, 4Department of Physiology and Pharmacology, Chang Gung University, Taoyuan, Taiwan, 5Department of
Cosmetic Science, Chang Gung Institute of Technology, Taoyuan, Taiwan
Abstract
Astringinin can attenuate organ injury following trauma-hemorrhage, the mechanism remains unknown. Protein kinase B/
hemeoxygenase-1 (Akt/HO-1) pathway exerts potent anti-inflammatory effects in various tissues. The aim of this study is to
elucidate whether Akt/HO-1 plays any role in astringinin-mediated attenuation of hepatic injury following trauma-
hemorrhage. For study this, male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure 35–40 mmHg
for 90 min) followed by fluid resuscitation. A single dose of astringinin (0.3 mg/kg body weight) with or without a PI3K
inhibitor (wortmannin) or a HO antagonist (chromium-mesoporphyrin) was administered during resuscitation. Various
parameters were measured at 24 h post-resuscitation. Results showed that trauma-hemorrhage increased plasma aspartate
and alanine aminotransferases (AST and ALT) concentrations and hepatic myeloperoxidase activity, cytokine induced
neutrophil chemoattractant (CINC)-1, CINC-3, intercellular adhesion molecule-1, and interleukin-6 levels. These parameters
were significantly improved in the astringinin-treated rats subjected to trauma-hemorrhage. Astringinin treatment also
increased hepatic Akt activation and HO-1 expression as compared with vehicle-treated trauma-hemorrhaged rats. Co-
administration of wortmannin or chromium-mesoporphyrin abolished the astringinin-induced beneficial effects on post-
resuscitation pro-inflammatory responses and hepatic injury. These findings collectively suggest that the salutary effects of
astringinin administration on attenuation of hepatic injury after trauma-hemorrhage are likely mediated via Akt dependent
HO-1 up-regulation.
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Introduction
Trauma-hemorrhage induces in excessive production of pro-
inflammatory mediators, such as cytokines and chemokines, which
play a significant role in the development of multiple organ
dysfunctions [1]. Following trauma-hemorrhage, neutrophil
movement and migration are mediated by multiple adhesion
molecules and pro-inflammatory mediators [2–4]. The intercellu-
lar adhesion molecule (ICAM)-1 enhances firm adhesion of
neutrophils to the vascular endothelium and is markedly up-
regulated after trauma-hemorrhage [2,5]. Furthermore, there is
convincing evidence that interleukin (IL)-6 plays a significant role
of organ injuries and is required for expression of adhesion
molecules and release of chemokines [2,6]. Chemokines, such as
cytokine-induced neutrophil chemoattractant (CINC)-1 and
CINC-3, are potent chemoattractants for neutrophils [2,5].
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B
(PKB; Akt) is known to be an endogenous negative regulatory
function, which serves to limit pro-inflammatory mediators and
chemotactic events in response to injury [7–9]. PI3K/Akt pathway
also play a pivotal role in the ability of neutrophils to undergo
chemotaxis [10,11]. Inhibition of the PI3K/Akt pathway with a
PI3K inhibitor wortmannin increases neutrophil migration to
chemotaxis [12] and increases serum cytokine levels in septic mice
[8,13]. Studies have also shown that activation of the PI3K
pathway protects organs or cells against ischemia-reperfusion
injury and hypoxia through suppression of the apoptosis
machinery [14]. There is now considerable evidence demonstrat-
ing an important role of PI3K/Akt in reducing neutrophil
infiltration and production of cytokines [15].
A growing body of evidence indicates that Akt activation
induces hemeoxygenase (HO)-1 [16,17], which is known to play a
protective role in many organs under various deleterious
conditions, including trauma-hemorrhage [18,19]. Up-regulation
of HO-1 causes a reduction of cytokines, adhesion molecules,
chemokines, and neutrophil accumulation, and ameliorates organ
injury in shock status [20,21]. Studies have also shown that
administration of 17b-estradiol, flutamide, or resveratrol after
trauma-hemorrhage increased HO-1 expression, which prevents
the organs from dysfunction and injury [18,19,21–23].
The liver is considered to be a critical organ following trauma-
hemorrhage. Hepatic dysfunction reflects the severity of tissue
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indicated that overproduction of those chemokines leads to hepatic
injury after trauma-hemorrhage [2,15]. Astringinin (piceatannol),
a resveratrol analogue with higher antioxidant activity and greater
radical scavenging capacity than resveratrol, has been shown to
possess anti-arrhythmic, anti-tumorigenic, and apoptosis-inducing
effects [24–27]. Previous studies have shown that astringinin can
reduce cytokine production and demonstrates cardioprotective
activities after shock-like states in ischemic-reperfused rat hearts
[28]. Our recent study also shown that astringinin can attenuate
hepatic injury after trauma-hemorrhage through inhibit of pro-
inflammatory mediator production [29]. However, it remains
unknown whether Akt/HO-1 play a critical role in the astringinin-
mediated organ protection after trauma-hemorrhage. We hypoth-
esized that the beneficial effects of astringinin after trauma-
hemorrhage are mediated via an Akt-dependent up-regulation of
HO-1. To test this hypothesis, we treated animals with astringinin
alone and in combination with the PI3K inhibitor wortmannin or
the HO antagonist chromium-mesoporphyrin after trauma-
hemorrhage. The effects of these treatments were then examined
to plasma alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) levels as well as hepatic tissue myeloperoxidase
(MPO) activity, IL-6, ICAM-1, chemokine (CINC-1 and CINC-3)
levels, and Akt/HO-1 expression after trauma-hemorrhage.
Materials and Methods
Animals
Adult male (275–325 g) Sprague-Dawley rats were used in this
study. The rats were obtained from the National Science Council
and were allowed to acclimatize to the animal facility for 1 wk
before the experiments. All animal experiments were performed
according to the guidelines of the Animal Welfare Act and The Guide
for Care and Use of Laboratory Animals from the National Institutes of
Health and approved by the Institutional Animal Care and Use
Committee of Chang Gung Memorial Hospital.
Trauma-Hemorrhage Procedure
Before initiation of the experiment, Male Sprague- Dawley rats
were fasted overnight but allowed free water access. Trauma-
hemorrhage and resuscitation was then performed as described
previously [2]. In brief, rats were anesthetized by isoflurane
inhalation, and a 5-cm midline laparotomy was performed to
induce soft tissue trauma. The abdominal wound was then closed
in layers, and polyethylene catheters (PE-50; Becton Dickinson &
Co., Sparks, MD) were placed in both femoral arteries and the
right femoral vein, and the incision sites were then closed. The
wounds were bathed with 1% lidocaine (Elkins-Sinn Inc., Cherry
Hill, NJ) throughout the operative procedure to reduce
postoperative pain. The rats were allowed to awaken, after
which they were bled rapidly within 10 minutes to a mean
arterial pressure of 35 to 40 mmHg. This level of hypotension
was maintained until the animals could no longer maintain a
mean arterial pressure of 40 mmHg unless some fluid in the form
of Ringer’s lactate was administered. This time was defined as
maximum bleed-out. After the maximal bleed-out, mean arterial
pressure was maintained between 35 to 40 mmHg until 40% of
the maximal bleed-out volume was returned in the form of
Ringer’s lactate solution (about 90 min from the onset of
bleeding). The rats were then resuscitated with four times the
volume of the shed blood with Ringer’s lactate for 60 minutes.
Thirty minutes before the end of the resuscitation period, the rats
received astringinin (0.3 mg/kg, intravenously) [29], astringinin
plus the PI3K inhibitor wortmannin (1 mg/kg, intravenously at
the beginning of resuscitation), co-administration of astringinin
with the HO inhibitor chromium-mesoporphyrin (2.5 mg/kg,
intraperitoneally at the beginning of resuscitation), or an equal
volume of the vehicle (about 0.2 mL, 10% DMSO). After
resuscitation, the catheters were removed, the vessels ligated, and
the skin incisions closed with sutures. Sham-operated animals
underwent all operative procedures, but neither hemorrhage nor
resuscitation was performed. Vehicle or astringinin was also
administered in sham-operated rats after catheters were placed.
The animals were humanely killed at 24 h after the end of
resuscitation or sham operation. In the experiment under review,
there were 8 rats in each group.
Measurement of Hepatic Injury
At 24 h after trauma-hemorrhage or sham operation, blood
samples with heparin were obtained and plasma was separated by
centrifugation. Hepatic injury was determined by measuring
plasma levels of AST and ALT using a colorimetric analyzer
(Dri-Chem 3000; Fuji Photo Film Co., Tokyo, Japan).
MPO Assay
MPO activity in homogenates of whole liver was determined as
described previously [2]. Frozen tissue samples were thawed and
suspended in phosphate buffer (pH 6.0) containing 0.5% hex-
adecyltrimethylammonium bromide (Sigma, St. Louis, MO). The
samples were sonicated on ice, centrifuged at 12,000 g for
15 minutes at 4uC, and an aliquot was transferred into phosphate
buffer (pH 6.0) containing 0.167 mg/mL o-dianisidine hydrochlo-
ride and 0.0005% hydrogen peroxide (Sigma). The change in
absorbance at 460 nm was measured spectrophotometrically for
5 minutes. MPO activity was calculated using a standard curve
that was generated using human MPO (Sigma), and values were
normalized to protein concentration.
Measurement of CINC-1, CINC-3, ICAM-1, and IL-6 Levels
The liver tissues were homogenized in PBS (1:10 weight:vo-
lume; pH 7.4) containing protease inhibitors (Complete Protease
Inhibitor Cocktail; Boehringer, Mannheim, Germany). The
homogenates were centrifuged at 2,000 g for 20 minutes at 4uC
and the supernatant was analyzed for the presence of CINC-1,
CINC-3, ICAM-1, and IL-6 using ELISA kits (R&D, Minneapolis,
MN) according to the manufacturer’s instructions and as described
previously [2]. An aliquot of the supernatant was used to
determined protein concentration by the Bio-Rad DC Protein
Assay (Bio-Rad, Hercules, CA).
Western Blot Assay
Protein aliquots were used to determine protein concentration
by the Bio-Rad DC Protein Assay (Bio-Rad, Hercules, CA).
Samples were mixed with 46sample buffer and were electropho-
resed on sodium dodecyl sulfate-polyacrylamide gels and trans-
ferred electrophoretically onto nitrocellulose paper. The mem-
branes were then incubated with antibodies to total Akt protein (1:
5000 dilution; Cell Signaling), phospho (p)-Akt (Ser473) (1:2000
dilution; Cell Signaling Technology Inc., Beverly, MA), antibodies
to HO-1 protein (1:6000 dilution; Chemicon International,
Temecula, CA), or antibodies to GAPDH (1:15000 dilution;
Abcam, Cambridge, MA) overnight at 4uC. The membranes were
later incubated with horseradish peroxidase-conjugated goat anti-
rabbit antibody or goat anti-mouse antibody for 1.5 h at room
temperature. After the final wash, membranes were probed using
enhanced chemiluminescence (Amersham, Piscataway, NJ) and
autoradiographed.
Effect of Astringinin after Trauma
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For statistical analysis we used the InStat 3.0 biostatistics
program (Graph Pad Software Inc., San Diego, CA). Results are
presented as mean 6 standard error of the mean (SEM). The data
were analyzed using one way analysis of variance and the Tukey
test, and differences were considered significant at p,0.05.
Results
Alteration in Plasma AST and ALT Levels
As shown in Figures 1A and 1B, no significant difference in
plasma AST and ALT levels was observed between vehicle- and
astringinin-treated sham groups. At 24 h after trauma-hemor-
rhage, there were significant increases in plasma AST and ALT
levels. Astringinin treatment attenuated the trauma-hemorrhage-
induced increase in plasma AST and ALT levels. To determine
whether the salutary effects of astringinin in attenuating hepatic
injury after trauma-hemorrhage were mediated via an Akt-
mediated activity, a group of astringinin-treated trauma-hemor-
rhage rats were administrated with the PI3 K inhibitor
wortmannin. The results indicated that administration of the
PI3K inhibitor wortmannin prevented the astringinin-induced
decrease in plasma AST and ALT levels. To determine whether
astringinin reduced hepatic injury after trauma-hemorrhage via a
HO-1-mediated pathway, a group of animals were administrated
with the HO enzyme inhibitor chromium-mesoporphyrin along
with astringinin. The results indicated that administration of
chromium-mesoporphyrin along with astringinin prevented the
astringinin-induced decrease in plasma AST and ALT levels.
Alteration in Hepatic MPO Activity
The result showed that there were no differences in hepatic
MPO activity between vehicle- and astringinin-treated sham
groups (Figure 2). After trauma-hemorrhage, MPO activity was
increased significantly in vehicle-treated rats compared with sham-
operated animals. Astringinin treatment attenuated this increase in
hepatic MPO activity. Administration of the PI3K inhibitor
wortmannin prevented the astringinin-mediated attenuation of
Figure 1. Effect of astringinin treatment on plasma AST (A) and ALT (B) in rats after sham operation (Sham) or trauma-hemorrhage
and resuscitation (T-H). Animals were treated with vehicle (Veh), astringinin (Ast), astringinin in combination with wortmannin (Ast+W),
wortmannin (W), astringinin in combination with chromium-mesoporphyrin (Ast+C), or chromium-mesoporphyrin (C). Data are shown as mean 6
SEM; n=8 rats in each group.
*p,0.05 compared with sham;
#p,0.05 compared with T-H+Veh, T-H+Ast+W, T-H+W, T-H+Ast+C, and T-H+C.
doi:10.1371/journal.pone.0025907.g001
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role of HO-1 in the astringinin-induced decrease in hepatic MPO
activity in trauma-hemorrhaged rats, rats were treated with the
HO inhibitor chromium-mesoporphyrin along with astringinin
after trauma-hemorrhage. The results indicated that administra-
tion of chromium-mesoporphyrin with astringinin prevented the
astringinin-induced decrease in hepatic MPO activity.
Alteration in Hepatic IL-6 Levels
There was no significant difference in hepatic IL-6 levels
between vehicle- and astringinin-treated sham groups (Figure 3).
Trauma-hemorrhage significantly increased hepatic IL-6 levels in
vehicle-treated rats compared with sham animals, which was
attenuated by astringinin treatment. Astringinin-mediated reduc-
tion in hepatic IL-6 levels was abolished by wortmannin co-
administration. In addition, astringinin-mediated reduction in
hepatic IL-6 levels was also abolished by chromium-mesoporphy-
rin co-administration.
Alteration in Hepatic CINC-1, CINC-3, and ICAM-1
Expressions
Trauma-hemorrhage significantly increased CINC-1, CINC-3,
and ICAM-1 expressions in the liver (Figures 4A and 4B and
Figure 5). Treatment with astringinin attenuated trauma-hemor-
rhage-induced increase in CINC-1, CINC-3, and ICAM-1
expressions. Co-administration of the PI3K inhibitor wortmannin
with astringinin prevented the astringinin-induced reduction in
CINC-1, CINC-3, and ICAM-1 expressions. Moreover, co-
administration of the HO inhibitor chromium-mesoporphyrin
with astringinin prevented the astringinin-induced reduction in
CINC-1, CINC-3, and ICAM-1 expressions in the trauma-
hemorrhaged group.
Akt Phosphorylation and Protein expression and Activity
There was no significant difference in Akt protein expression
between sham and trauma-hemorrhaged rats (Figure 6). However,
the Akt activity, as determined by its phosphorylation, was
significantly decreased after trauma-hemorrhage. Administration
of astringinin after trauma-hemorrhage restored Akt activity to the
levels observed in sham animals. The increase in p-Akt induced by
astringinin was abolished by administration of wortmannin along
with astringinin (Figure 6).
HO-1 Expression in the Liver
Trauma-hemorrhage induced a significant increase in hepatic
HO-1 protein expression compared with shams (Figure 7).
Administration of astringinin after trauma-hemorrhage induced
a further significant increase in hepatic HO-1 protein expression
compared with vehicle-treated trauma-hemorrhaged rats. Since
astringinin up-regulated hepatic HO-1 after trauma-hemorrhage,
we examined whether administration of PI3K inhibitor wortman-
nin had any effect on HO-1 protein level. The result of these
experiments indicated that co-administration of wortmannin
prevented the astringinin-induced up-regulation of hepatic HO-1
after trauma-hemorrhage (Figure 7).
Discussion
The present study indicate that at 24 h after trauma-
hemorrhage, plasma ALT and AST concentrations, hepatic
MPO activity, IL-6, CINC-1, CINC-3, and ICAM-1 levels are
markedly increased in male rats. Administration of a single dose of
astringinin during resuscitation could attenuate the increase in
those inflammatory markers. Administration of astringinin also
prevented the trauma-hemorrhage-induced decrease in hepatic p-
Akt expression. A difference in the magnitude of HO-1 expression
in the liver of male rats with or without astringinin treatment after
trauma-hemorrhage was also found. Administration of the PI3K
inhibitor (wortmannin) or the HO inhibitor (chromium-mesopor-
phyrin) along with astringinin after trauma-hemorrhage abolished
the astringinin-induced above effects. These results collectively
suggest that the salutary effects of astringinin seem to be mediated
via Akt and the up-regulation of HO-1.
Induction of HO-1 plays an important role in organ protection
against the deleterious pathophysiological conditions such as
trauma-hemorrhage, ischemia, oxidative stress, endotoxemia and
wound healing [3,21,30,31]. In this study, we observed that HO-1
level is increased following trauma-hemorrhage and that up-
Figure 2. Effect of astringinin treatment on hepatic MPO
activity in rats after sham operation (Sham) or trauma-
hemorrhage and resuscitation (T-H). Animals were treated with
vehicle (Veh), astringinin (Ast), astringinin in combination with
wortmannin (Ast+W), wortmannin (W), astringinin in combination with
chromium-mesoporphyrin (Ast+C), or chromium-mesoporphyrin (C).
Data are shown as mean 6 SEM; n=8 rats in each group.
*p,0.05
compared with sham;
#p,0.05 compared with T-H+Veh, T-H+Ast+W, T-
H+W, T-H+Ast+C, and T-H+C.
doi:10.1371/journal.pone.0025907.g002
Figure 3. Effect of astringinin treatment on hepatic IL-6 levels
in rats after sham operation (Sham) or trauma-hemorrhage
and resuscitation (T-H). Animals were treated with vehicle (Veh),
astringinin (Ast), astringinin in combination with wortmannin (Ast+W),
wortmannin (W), astringinin in combination with chromium-mesopor-
phyrin (Ast+C), or chromium-mesoporphyrin (C). Data are shown as
mean 6 SEM; n=8 rats in each group.
*p,0.05 compared with sham;
#p,0.05 compared with T-H+Veh, T-H+Ast+W, T-H+W, T-H+Ast+C, and
T-H+C.
doi:10.1371/journal.pone.0025907.g003
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This initial increase in HO-1 is likely independent of Akt, as there
was a concomitant, significant decrease in Akt phosphorylation in
vehicle-treated trauma-hemorrhage rats compared with sham-
operated rats. However, the astringinin-mediated increase in HO-
1 is found to be Akt-dependent, because co-administration of
wortmannin with astringinin abolished the increase in HO-1 and
the salutary effects of astringinin treatment in the liver.
Akt phosphorylation is reported to be hepatoprotective after
trauma-hemorrhage [15]. Our previous studies have shown that
up-regulation of PI3K/Akt pathway attenuates overproduction of
cytokines, chemokines, adhesion molecules, and neutrophil
accumulation after trauma-hemorrhage [2,5]. In this study, we
found that astringinin-induced attenuation of hepatic injury was
likely via increases in Akt activation, which were blocked by the
PI3 K inhibitor wortmannin. Our results also suggest that the
salutary effects of astringinin are mediated via Akt-dependent HO-
1 up-regulation. A growing body of evidence indicates that HO-1
expression is up-regulated after hemorrhagic shock, and that its
induction seems to play a central role in the preservation of organ
microcirculation under such conditions [21]. The finding that
treatment of animals with wortmannin, which blocks Akt,
abolished astringinin-induced up-regulation of HO-1 after trau-
ma-hemorrhage suggests that administration of astringinin after
trauma-hemorrhage up-regulates HO-1 via the Akt-related
pathway.
Chemokines (C-X-C) play an important role in trauma-
hemorrhage-induced extravasation of neutrophils into the liver
[32]. Previous studies have demonstrated that hepatic injury is
associated with an increased neutrophil accumulation [33]. The
infiltration of neutrophils in the liver is also accompanied with
increased expression of adhesion molecules and elevation of locally
produced cytokine/chemokine levels [33]. IL-6 is an important
mediator in hepatic inflammation, and is required for adhesion
molecule expression and chemokine production [33]. CINC-1 and
CINC-3 levels also correlate with tissue MPO activity, a marker of
neutrophil infiltration, after trauma-hemorrhage [2]. In this study,
our results indicate that trauma-hemorrhage results in a significant
increase in hepatic pro-inflammatory cytokine/chemokine levels
and ICAM-1 expression, which are accompanied with increased
Figure 4. Effect of astringinin treatment on hepatic CINC- 1 (A) and CINC-3 (B) levels in rats after sham operation (Sham) or trauma-
hemorrhage and resuscitation (T-H). Animals were treated with vehicle (Veh), astringinin (Ast), astringinin in combination with wortmannin
(Ast+W), wortmannin (W), astringinin in combination with chromium-mesoporphyrin (Ast+C), or chromium-mesoporphyrin (C). Data are shown as
mean 6 SEM; n=8 rats in each group.
*p,0.05 compared with sham;
#p,0.05 compared with T-H+Veh, T-H+Ast+W, T-H+W, T-H+Ast+C, and T-H+C.
doi:10.1371/journal.pone.0025907.g004
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trauma-hemorrhage attenuated these pro-inflammatory mediators
and attenuated hepatic injury under those conditions.
In the present study, astringinin demonstrates a function in
regulating the production of pro-inflammatory mediators. The
ability of astringinin to modulate expression of inflammatory
cytokines as well as chemokines and adhesion molecules suggests a
role for astringinin in the regulation of hepatic inflammation. Our
study further indicates that astringinin administration after
trauma-hemorrhage decreases pro-inflammatory mediator levels
and attenuates liver injury likely through Akt-mediated up-
regulation of HO-1. Administration of wortmannin or chromi-
um-mesoporphyrin in sham-operated animals was not performed
in the present study. Previous studies have shown that adminis-
tration of P13K inhibitor wortmannin or HO inhibitor chromium-
mesoporphyrin does not have additional hepatotoxic effect in the
sham-operated rats [18,34]. It may suggest that P13K inhibitor
and HO inhibitor abolish the protective effects of astringinin
primarily due to their molecular effect rather than toxic effect itself
per se.
In conclusion, this study indicates that astringinin administra-
tion ameliorates hepatic injury and IL-6 production after trauma-
hemorrhage. The decrease in hepatic injury after astringinin
administration is likely due to a reduction of hepatic neutrophil
accumulation associated with down-regulation of CINC-1, CINC-
3, and ICAM-1. Suppression in hepatic cytokine production by
astringinin seems to contribute to the decrease in hepatic
expressions of chemokine and adhesion molecule. Blockade of
Akt activation or HO-1 and the associated deterioration of the
examined parameters suggest that the reduction of neutrophil
accumulation in the liver is in part mediated via an Akt dependent
HO-1 pathway. Although the precise mechanism of the salutary
effects of astringinin in attenuating hepatic injury and the
contribution of Akt/HO-1 in protecting against hepatic injury
after trauma-hemorrhage remain unclear, our studies provides
evidence that Akt-dependent up-regulation of HO-1 may be
critical in reducing hepatic injury after trauma-hemorrhage. These
findings also have implications for the potential utility of
astringinin as a clinical adjunct to trauma-hemorrhage.
Figure 5. Effect of astringinin treatment on hepatic ICAM-1
levels in rats after sham operation (Sham) or trauma-hemor-
rhage and resuscitation (T-H). Animals were treated with vehicle
(Veh), astringinin (Ast), astringinin in combination with wortmannin
(Ast+W), wortmannin (W), astringinin in combination with chromium-
mesoporphyrin (Ast+C), or chromium-mesoporphyrin (C). Data are
shown as mean 6 SEM; n=8 rats in each group.
*p,0.05 compared
with sham;
#p,0.05 compared with T-H+Veh, T-H+Ast+W, T-H+W, T-
H+Ast+C, and T-H+C.
doi:10.1371/journal.pone.0025907.g005
Figure 6. Hepatic p-Akt and Akt protein expressions from
shams receiving vehicle (Sham+Veh; lane 1) or astringinin
(Sham+Ast; lane 2), trauma-hemorrhage receiving vehicle (T-
H+Veh; lane 3), astringinin (T-H+Ast; lane 4), astringinin and
wortmannin (T-H+Ast+W; lane 5) or wortmannin (T-H+W; lane
6). Blots were reprobed for GAPDH for equal protein loading in various
lanes. The bands were analyzed using densitometry and the values are
presented as mean 6 SEM; n=5 rats per group.
*p,0.05 versus all other
groups.
doi:10.1371/journal.pone.0025907.g006
Figure 7. Hepatic HO-1 protein expression from shams
receiving vehicle (Sham+Veh; lane 1) or astringinin (Sham+Ast;
lane 2), trauma-hemorrhage receiving vehicle (T-H+Veh; lane
3), astringinin (T-H+Ast; lane 4), astringinin and wortmannin
(T-H+Ast+W; lane 5), or wortmannin (T-H+W; lane 6). For equal
protein loading, membranes were reprobed for GAPDH using mouse
monoclonal antibody. The bands were analyzed using densitometry
and the values are presented as mean 6 SEM; n=5 rats per group.
*p,0.05 compared with sham;
#p,0.05 compared with T-H+Veh, T-
H+Ast+W, and T-H+W.
doi:10.1371/journal.pone.0025907.g007
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